![Foto de HERMINIA](/img/nophoto.png)
HERMINIA
GONZALEZ NAVARRO
TITULAR DE UNIVERSIDAD
Publications (59) Publications de HERMINIA GONZALEZ NAVARRO
2024
-
Light deficiency in Apoe−/−mice increases atheroma plaque size and vulnerability by modulating local immunity
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 4
2023
-
CCL17 and CCL22 chemokines are upregulated in human obesity and play a role in vascular dysfunction
Frontiers in Endocrinology, Vol. 14
-
Ruleta de palabras: uso para consolidar el aprendizaje en Bioquímica
In-Red 2023. IX Congreso Nacional de Innovación Educativa y Docencia en Red: Modelos transformadores docentes para un aprendizaje a lo largo de la vida (Universidad Politécnica de Valencia = Universitat Politècnica de València), pp. 944-950
-
Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor
Clínica e investigación en arteriosclerosis, Vol. 35, Núm. 1, pp. 1-11
2022
-
Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived G Protein Coupled Receptor Agonists
Nutrients, Vol. 14, Núm. 18
-
Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor
Clinica e Investigacion en Arteriosclerosis
2021
-
Dissecting abdominal aortic aneurysm is aggravated by genetic inactivation of light (Tnfsf14)
Biomedicines, Vol. 9, Núm. 11
-
Overexpression of glucose 6 phosphate dehydrogenase preserves mouse pancreatic beta cells function until late in life
Free Radical Biology and Medicine, Vol. 164, pp. 149-153
-
Postprandial triglyceridaemia is modulated by insulin resistance but not by grade of obesity in abdominal and morbid obese subjects
International Journal of Clinical Practice, Vol. 75, Núm. 4
-
Therapies for the treatment of cardiovascular disease associated with type 2 diabetes and dyslipidemia
International Journal of Molecular Sciences, Vol. 22, Núm. 2, pp. 1-27
2020
-
A year in the life of the EU-CardioRNA COST action: CA17129 catalysing transcriptomics research in cardiovascular disease
Non-coding RNA, Vol. 6, Núm. 2
-
Dapagliflozin does not modulate atherosclerosis in mice with insulin resistance
International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-18
-
Impact of cholesterol metabolism in immune cell function and atherosclerosis
Nutrients, Vol. 12, Núm. 7, pp. 1-19
-
Srebf2 locus overexpression reduces body weight, total cholesterol and glucose levels in mice fed with two different diets
Nutrients, Vol. 12, Núm. 10, pp. 1-15
-
TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity
Cell Reports, Vol. 33, Núm. 4
2019
-
Aging in Rodents
Encyclopedia of Biomedical Gerontology: Volume 1-3 (Elsevier), pp. V1-73-V1-87
-
Aging in rodents
Encyclopedia of Biomedical Gerontology (Elsevier), pp. 73-87
-
Anti-inflammatory Therapies for Cardiovascular Disease: Signaling Pathways and Mechanisms
Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 767-773
-
Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus
Translational Research, Vol. 203, pp. 31-48
-
Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis
Diabetologia, Vol. 62, Núm. 11, pp. 2143-2157